Exploring mechanism of enzyme catalysis by on-chip transient kinetics coupled with global data analysis and molecular modeling

Chem ◽  
2021 ◽  
Author(s):  
David Hess ◽  
Veronika Dockalova ◽  
Piia Kokkonen ◽  
David Bednar ◽  
Jiri Damborsky ◽  
...  
Author(s):  
Rommel Estores ◽  
Pascal Vercruysse ◽  
Karl Villareal ◽  
Eric Barbian ◽  
Ralph Sanchez ◽  
...  

Abstract The failure analysis community working on highly integrated mixed signal circuitry is entering an era where simultaneously System-On-Chip technologies, denser metallization schemes, on-chip dissipation techniques and intelligent packages are being introduced. These innovations bring a great deal of defect accessibility challenges to the failure analyst. To contend in this era while aiming for higher efficiency and effectiveness, the failure analysis environment must undergo a disruptive evolution. The success or failure of an analysis will be determined by the careful selection of tools, data and techniques in the applied analysis flow. A comprehensive approach is required where hardware, software, data analysis, traditional FA techniques and expertise are complementary combined [1]. This document demonstrates this through the incorporation of advanced scan diagnosis methods in the overall analysis flow for digital functionality failures and supporting the enhanced failure analysis methodology. For the testing and diagnosis of the presented cases, compact but powerful scan test FA Lab hardware with its diagnosis software was used [2]. It can therefore easily be combined with the traditional FA techniques to provide stimulus for dynamic fault localizations [3]. The system combines scan chain information, failure data and layout information into one viewing environment which provides real analysis power for the failure analyst. Comprehensive data analysis is performed to identify failing cells/nets, provide a better overview of the failure and the interactions to isolate the fault further to a smaller area, or to analyze subtle behavior patterns to find and rationalize possible faults that are otherwise not detected. Three sample cases will be discussed in this document to demonstrate specific strengths and advantages of this enhanced FA methodology.


This chapter explores how the Alouette satellite’s reorientation of global data flows and mass-production of ionograms altered the natural order at the core of DRTE’s research. The satellite’s unexpected reliability demanded an automated system of data analysis. Automation, when applied to the ionogram, effaced the complexity used to characterize the ionosphere above Canada and explain violent communications disruptions. The chapter first analyzes the debates over the organization of the satellite’s global ground station network, the control of the satellite, the collaboration with NASA, and the sharing of data. It then examines how these considerations formed part of the technical design of the satellite, and specifically how they required a system for mass-producing ionograms from global data gathered around the world. The chapter’s final section focuses on the resulting problems of data analysis that this system produced and the new reading techniques devised to analyze the overwhelming number of records.


Toxicon ◽  
2006 ◽  
Vol 48 (6) ◽  
pp. 690-701 ◽  
Author(s):  
Paula Alvarez Abreu ◽  
Magaly Girão Albuquerque ◽  
Carlos Rangel Rodrigues ◽  
Helena Carla Castro

1999 ◽  
Vol 53 ◽  
pp. 95-99
Author(s):  
Rune Fossheim ◽  
Astri Rogstad ◽  
Rubén A. Toscano ◽  
Raymundo Cea-Olivares ◽  
Jorma Mattinen ◽  
...  

2020 ◽  
Vol 20 (19) ◽  
pp. 1761-1770
Author(s):  
Devadasan Velmurugan ◽  
R. Pachaiappan ◽  
Chandrasekaran Ramakrishnan

Introduction: Structure-based drug design is a wide area of identification of selective inhibitors of a target of interest. From the time of the availability of three dimensional structure of the drug targets, mostly the proteins, many computational methods had emerged to address the challenges associated with drug design process. Particularly, drug-likeness, druggability of the target protein, specificity, off-target binding, etc., are the important factors to determine the efficacy of new chemical inhibitors. Objective: The aim of the present research was to improve the drug design strategies in field of design of novel inhibitors with respect to specific target protein in disease pathology. Recent statistical machine learning methods applied for structural and chemical data analysis had been elaborated in current drug design field. Methods: As the size of the biological data shows a continuous growth, new computational algorithms and analytical methods are being developed with different objectives. It covers a wide area, from protein structure prediction to drug toxicity prediction. Moreover, the computational methods are available to analyze the structural data of varying types and sizes of which, most of the semi-empirical force field and quantum mechanics based molecular modeling methods showed a proven accuracy towards analysing small structural data sets while statistics based methods such as machine learning, QSAR and other specific data analytics methods are robust for large scale data analysis. Results: In this present study, the background has been reviewed for new drug lead development with respect specific drug targets of interest. Overall approach of both the extreme methods were also used to demonstrate with the plausible outcome. Conclusion: In this chapter, we focus on the recent developments in the structure-based drug design using advanced molecular modeling techniques in conjunction with machine learning and other data analytics methods. Natural products based drug discovery is also discussed.


1974 ◽  
Vol 49 (1) ◽  
pp. 11-20 ◽  
Author(s):  
Christian MOUTTET ◽  
Francis FOUCHIER ◽  
Joannes NARI ◽  
Jacques RICARD

Sign in / Sign up

Export Citation Format

Share Document